You are here

  • Home
  • Archive
  • Volume 11, Issue Suppl 1
  • 833 CRB-601, a selective integrin αvβ8-blocking antibody, prevents TGFβ activation, promotes immune cell remodeling, and exhibits potent antitumor activity

Article metrics

Article menu

Download PDFPDF

Regular and Young Investigator Award Abstracts
Combination Immunotherapies
833 CRB-601, a selective integrin αvβ8-blocking antibody, prevents TGFβ activation, promotes immune cell remodeling, and exhibits potent antitumor activity

 

Online download statistics by month:

Online download statistics by month: November 2023 to June 2025

AbstractFullPdf
Nov 202310808
Dec 20233205
Jan 20242102
Feb 20242605
Mar 20242603
Apr 20241602
May 20242002
Jun 2024803
Jul 20241802
Aug 20241001
Sep 20241200
Oct 20241804
Nov 20242408
Dec 20241605
Jan 202516015
Feb 2025608
Mar 20250014
Apr 20251013
May 2025004
Jun 2025004
Total3780108